van Spronsen FJ - Search Results

1

The truth of treating patients with phenylketonuria after childhood: the need for a new guideline.

van Spronsen FJ, Burgard P. van Spronsen FJ, et al. J Inherit Metab Dis. 2008 Dec;31(6):673-9. doi: 10.1007/s10545-008-0918-6. Epub 2008 Aug 12. J Inherit Metab Dis. 2008. PMID: 18690552 Review.

2

Tyrosinaemia type I: considerations of treatment strategy and experiences with risk assessment, diet and transplantation.

van Spronsen FJ, Smit GP, Wijburg FA, Thomasse Y, Visser G, Heymans HS. van Spronsen FJ, et al. J Inherit Metab Dis. 1995;18(2):111-4. doi: 10.1007/BF00711742. J Inherit Metab Dis. 1995. PMID: 7564222 No abstract available.

3

Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/postprandial) in patients with phenylketonuria: effect of sample timing.

van Spronsen FJ, van Rijn M, van Dijk T, Smit GP, Reijngoud DJ, Berger R, Heymans HS. van Spronsen FJ, et al. Among authors: van rijn m, van dijk t. Pediatrics. 1993 Oct;92(4):570-3. Pediatrics. 1993. PMID: 8414829

4

Phenylketonuria: plasma phenylalanine responses to different distributions of the daily phenylalanine allowance over the day.

van Spronsen FJ, van Dijk T, Smit GP, van Rijn M, Reijngoud DJ, Berger R, Heymans HS. van Spronsen FJ, et al. Among authors: van rijn m, van dijk t. Pediatrics. 1996 Jun;97(6 Pt 1):839-44. Pediatrics. 1996. PMID: 8657524 Clinical Trial.

5

Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria.

van Spronsen FJ, van Dijk T, Smit GP, van Rijn M, Reijngoud DJ, Berger R, Heymans HS. van Spronsen FJ, et al. Among authors: van rijn m, van dijk t. Am J Clin Nutr. 1996 Dec;64(6):916-21. doi: 10.1093/ajcn/64.6.916. Am J Clin Nutr. 1996. PMID: 8942417

6

Does impaired growth of PKU patients correlate with the strictness of dietary treatment? National Dutch PKU Steering Committee.

van Spronsen FJ, Verkerk PH, van Houten M, Smit GP, van der Meer SB, Bakker HD, Sengers RC. van Spronsen FJ, et al. Among authors: van houten m, van der meer sb. Acta Paediatr. 1997 Aug;86(8):816-8. doi: 10.1111/j.1651-2227.1997.tb08603.x. Acta Paediatr. 1997. PMID: 9307159

7

Phenylketonuria. The in vivo hydroxylation rate of phenylalanine into tyrosine is decreased.

van Spronsen FJ, Reijngoud DJ, Smit GP, Nagel GT, Stellaard F, Berger R, Heymans HS. van Spronsen FJ, et al. J Clin Invest. 1998 Jun 15;101(12):2875-80. doi: 10.1172/JCI737. J Clin Invest. 1998. PMID: 9637722 Free PMC article.

8

Behaviour and school achievement in patients with early and continuously treated phenylketonuria.

Stemerdink BA, Kalverboer AF, van der Meere JJ, van der Molen MW, Huisman J, de Jong LW, Slijper FM, Verkerk PH, van Spronsen FJ. Stemerdink BA, et al. Among authors: van spronsen fj, van der molen mw, van der meere jj. J Inherit Metab Dis. 2000 Sep;23(6):548-62. doi: 10.1023/a:1005669610722. J Inherit Metab Dis. 2000. PMID: 11032330

9

Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets.

van Spronsen FJ, van Rijn M, Bekhof J, Koch R, Smit PG. van Spronsen FJ, et al. Among authors: van rijn m. Am J Clin Nutr. 2001 Feb;73(2):153-7. doi: 10.1093/ajcn/73.2.153. Am J Clin Nutr. 2001. PMID: 11157309 Review.

10

Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet.

van Spronsen FJ, Smit PG, Koch R. van Spronsen FJ, et al. J Inherit Metab Dis. 2001 Feb;24(1):1-4. doi: 10.1023/a:1005689232358. J Inherit Metab Dis. 2001. PMID: 11286377 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters